Table 1 Patient demographics and baseline characteristics. All percentages are from the total number of patients in the study.
| No of patients (eyes) | 125 |
| Mean age (SD) (years) | 71 (12.3) |
| Male/female | 66/59 |
| Mean follow up in months (SD) (range) | 24 (5.7) (6–32) |
| “Trabeculectomy” procedures | 61 (48.8%) |
| Trabeculectomy | 26 (20.8%) |
| Phaco‐trabeculectomy | 24 (19.2%) |
| deep sclerectomy converted to trabeculectomy | 05 (4.0%) |
| deep sclerectomy intraoperative perforation | 06 (4.8%) |
| “Deep sclerectomy” procedures | 64 (51.2%) |
| Deep sclerectomy | 48 (38.4%) |
| Phaco deep sclerectomy | 16 (12.8%) |
| Previous laser | |
| Nd:YAG laser peripheral iridotomy | 2 (1.6%) |
| Argon laser trabeculoplasty | 3 (2.4%) |
| Previous surgeries* | |
| Trabeculectomy | 15 (12%) |
| Deep sclerectomy | 2 (1.6%) |
| Phaco‐trabeculectomy | 1 (0.8%) |
| Combined ECCE and trabeculectomy | 2 (1.6%) |
| Trabeculectomy + MMC, ECCE | 1 (0.8%) |
| ECCE | 4 (3.2%) |
| Phacoemulsification | 3 (2.4%) |
| Retinal detachment surgery | 1 (0.8%) |
| MMC application concentration and duration of application | |
| 0.1 mg/ml for 1 minute | 2 (1.6%) |
| 0.2 mg/ml for 1 minute | 7 (5.6%) |
| 0.2 mg/ml for 2 minutes | 98 (78.4%) |
| 0.2 mg/ml for 3 minutes | 15 (12.0%) |
| 0.4 mg/ml for 3 minutes | 3 (2.4%) |
ECCE, extracapsular cataract extraction.
*Some eyes had more than one surgery.